Modeled speed is a PK→PD construct describing how absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, and clearance shape the rising-phase geometry for sildenafil and avanafil. “Speed” refers strictly to modeled PK→PD behavior, not real-world performance. Absorption rate determines rising-phase steepness, absorption timing determines temporal alignment, solubility determines dissolution-driven availability, and gastric emptying determines input arrival. Distribution loading determines early central availability, while distribution geometry and clearance geometry determine how rapidly material spreads or is removed. First-pass metabolism determines the systemic fraction entering the modeled circulation. These PK parameters generate concentration-time trajectories. PD interpretation then determines modeled onset and peak geometry: threshold placement defines the onset boundary, binding sensitivity transforms concentration differences, coupling geometry shapes downstream transitions, and PD noise bands add interpretation variability. The resulting framework separates modeled timing coordinates from any real-world interpretation. This comparison remains model-defined and parameterized.
Modeled onset comparison follows the geometry of the rising concentration trajectory. Faster modeled absorption steepens the rising phase, earlier absorption timing shifts that phase leftward, solubility determines dissolution-driven availability, and gastric-emptying variability shifts input arrival. Distribution loading determines early central-compartment concentration, while distribution geometry determines how rapidly absorbed material spreads across compartments, while redistribution timing shifts later compartmental equilibration. Clearance geometry determines removal dynamics, and first-pass metabolism determines the systemic fraction available to the modeled trajectory. Concentration-dependent clearance can alter curvature as concentration changes. These mechanisms interact: faster modeled absorption can be offset by faster modeled clearance, while earlier modeled timing can be offset by broader distribution geometry. Under onset modeling, PK geometry supplies the input curve that PD parameters transform through threshold placement, binding sensitivity, and coupling geometry. PD noise bands then represent a modeled uncertainty region around threshold crossing. This framework compares parameterized trajectories rather than predicting real-world onset.
Modeled peak, Tmax, and Cmax comparison depends on how PK trajectories are transformed by the PD layer. Threshold placement determines the concentration coordinate at which the modeled PD system is considered to cross its onset boundary. Binding sensitivity determines how concentration differences are transformed into binding differences; higher modeled sensitivity can expand separation, while lower sensitivity can compress it. Coupling geometry determines how binding is mapped into downstream PD signals; shallow slopes broaden transitions, while steep slopes compress them. PD noise bands widen or narrow modeled interpretation regions. Sildenafil and avanafil can therefore be represented by differing parameter sets for absorption rate, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, Tmax geometry, and Cmax geometry. The resulting PK→PD mapping can expand or compress modeled speed differences without establishing a real-world speed ordering. Peak geometry describes modeled maximum timing and magnitude, Tmax locates the modeled concentration maximum, and Cmax specifies its modeled concentration value.
PK speed geometry is generated by the shape of the modeled concentration-time trajectory. Absorption rate controls the slope of the incoming phase, while absorption timing controls when that phase begins relative to the model clock. Solubility influences the availability of dissolved material, and gastric emptying controls the timing of gastrointestinal input reaching the absorption region. Distribution loading determines the initial allocation into the central compartment, while distribution geometry determines subsequent compartmental spread and equilibration. First-pass metabolism modifies the systemic fraction entering the modeled trajectory. Clearance geometry governs removal, shaping the descending phase and potentially changing the curvature of the full profile. Concentration-dependent clearance can further make removal geometry vary across concentration ranges. Together, these parameters establish the PK trajectory that serves as the input to PD transformation. A speed comparison therefore concerns differences in modeled curve geometry, not an observed or predicted real-world performance measure. See the modeled absorption rate construct for the rising-phase component.
PK variability can be represented by changing one or more parameter values across modeled trajectories rather than by assuming a single fixed curve. Variation in absorption rate changes rising-phase steepness; variation in absorption timing shifts the input window; and variation in gastric emptying changes when absorbed material becomes available. Solubility changes the dissolution contribution, while distribution loading and distribution geometry alter early and intermediate concentration placement. First-pass metabolism and bioavailability change systemic exposure, and clearance geometry changes the rate and curvature of concentration decline. Redistribution timing can shift the relationship between early central concentration and later compartmental behavior. These interacting parameters can generate narrow, broad, early-shifted, late-shifted, steep, or shallow modeled speed windows. The comparison remains a parameter-space exercise: each trajectory represents a defined PK configuration, and the resulting spread describes modeled geometric variability. No single curve is treated as a real-world prediction. The distribution speed construct isolates the distribution component.
| PK Domain | Speed Interaction | Link |
|---|---|---|
| Absorption Rate | Steeper rising phase. | absorption rate |
| Distribution Geometry | Compartmental spread. | distribution speed |
| Clearance | Removal geometry. | elimination speed |
Threshold placement determines the concentration coordinate at which the modeled PD system is considered to cross its onset boundary. For the same PK trajectory, a lower threshold can produce an earlier modeled crossing, while a higher threshold can produce a later modeled crossing. This relationship is geometric rather than clinical: it describes where a defined PD boundary intersects the concentration-time curve. Binding sensitivity then determines how strongly changes in concentration are translated into modeled receptor-binding differences. Coupling geometry maps those binding changes into the downstream PD signal, potentially changing the apparent steepness of the transition. PD noise bands can surround the threshold boundary, representing a modeled region rather than a fixed point. Consequently, identical PK trajectories can yield different modeled onset coordinates when PD parameters differ, while different PK trajectories can converge when their threshold and transformation parameters compensate. The PD speed construct frames these transformations without converting them into real-world timing predictions.
Binding sensitivity, coupling geometry, and PD noise bands shape how PK differences appear after the concentration trajectory is transformed by the PD model. Binding sensitivity controls the magnitude of modeled binding change associated with a concentration difference, so higher sensitivity can enlarge separation between trajectories while lower sensitivity can compress it. Coupling geometry determines how binding is transferred into a downstream signal, with slope and curvature controlling the shape of that transformation. PD noise bands add a modeled spread around the transformed signal, which can make closely spaced trajectories overlap or make separated trajectories appear less sharply distinguished. These modifiers operate after or alongside the PK trajectory and therefore can change the visual geometry of modeled onset, peak, and transition regions without changing the underlying PK parameters. The PK speed construct supplies the concentration-time geometry that the PD layer transforms.
| PD Domain | Speed Effect | Link |
|---|---|---|
| Threshold Placement | Earlier/later onset. | onset time |
| Binding Sensitivity | Amplification/compression. | onset variability comparison |
| Coupling Geometry | Slope-driven shaping. | peak variability comparison |
Modeled speed differences arise from the geometry of parameterized PK trajectories and their PD transformation. Absorption rate, absorption timing, gastric emptying, solubility, and absorption-window width shape the rising concentration phase. Distribution loading, distribution geometry, and redistribution timing shape early and intermediate concentration placement. First-pass metabolism and bioavailability determine the systemic fraction represented in the modeled circulation, while clearance geometry and concentration-dependent clearance shape removal and curvature. Tmax and Cmax describe features of the resulting concentration profile. The PD layer then applies threshold placement, binding sensitivity, coupling geometry, and noise bands to transform concentration differences into modeled onset and peak differences. Parameter combinations can produce similar modeled profiles, while small changes can alter trajectory geometry when other mechanisms do not compensate.
The principal PK mechanisms are absorption rate, absorption timing, gastric emptying, solubility, absorption-window width, distribution loading, distribution geometry, redistribution timing, first-pass metabolism, bioavailability, clearance geometry, and concentration-dependent clearance. Absorption establishes the timing and shape of incoming material, while distribution determines how that material is allocated and redistributed across modeled compartments. First-pass metabolism and bioavailability determine the systemic fraction represented after input processing. Clearance determines removal and can modify concentration curvature. Tmax identifies the modeled location of maximum concentration, while Cmax identifies the modeled maximum concentration. These mechanisms interact rather than operating as independent switches. A steep absorption phase can coexist with faster clearance, producing different early and later trajectory geometry. Speed comparison therefore evaluates the combined concentration-time profile produced by the PK parameter set.
PD mechanisms shape how the modeled concentration trajectory is interpreted as onset and peak geometry. Threshold placement establishes the concentration boundary used to define modeled onset, so moving that boundary changes its intersection with the PK curve. Binding sensitivity determines how concentration changes are converted into modeled binding changes, controlling trajectory separation. Coupling geometry maps binding into a downstream PD signal and can alter slope, curvature, and transition width. PD noise bands introduce a modeled region around the transformed signal, allowing trajectories to overlap or remain distinct. Peak interpretation therefore depends on the transformed trajectory rather than concentration alone. The same Cmax geometry can map differently under different PD parameterizations. The resulting onset and peak coordinates remain properties of the specified model.
Sildenafil and avanafil can differ in modeled speed geometry when their parameter sets assign different values or functional forms to absorption, distribution, metabolism, clearance, and PD transformation. Differences in absorption rate or timing can change rising-phase slope and temporal alignment. Gastric-emptying and solubility parameters can alter modeled input arrival and availability, while absorption-window width can broaden or narrow the incoming phase. Distribution loading, distribution geometry, and redistribution timing can modify early concentration placement. First-pass metabolism and bioavailability can alter systemic exposure, while clearance geometry can reshape the declining phase. At the PD level, threshold placement, binding sensitivity, coupling geometry, and noise bands can transform those PK differences into different modeled onset and peak geometries. The comparison reflects the chosen parameterization and model structure.
PK→PD mapping explains modeled speed differences by treating the PK concentration-time curve as an input to a defined PD transformation. PK parameters determine the trajectory: absorption controls the incoming phase, distribution controls compartmental allocation, first-pass processes determine systemic availability, and clearance controls removal. Tmax and Cmax emerge as geometric descriptors of that trajectory. The PD layer then places a threshold on concentration, applies binding sensitivity, maps binding through coupling geometry, and can add a noise band around the resulting signal. A small PK shift can produce a large or small modeled timing difference depending on threshold location and transformation slope. The final speed geometry is a property of the combined PK and PD model, describing parameterized trajectories rather than observed real-world timing or effectiveness.